Deoxycorticosterone
|
Basic information |
| Metabolite name | Deoxycorticosterone |
 | HMDB0000016 |
 |
C03205 |
 |
6166 |
| Synonyms | 11-Deoxy corticosterone |
| No. of studies | 7 |
|
Basic information |
| Metabolite name | Deoxycorticosterone |
| HMDB0000016 |
|
C03205 |
|
6166 |
| Synonyms | 11-Deoxy corticosterone |
| No. of studies | 7 |
|
Relationship between Deoxycorticosterone and depression (count: 7) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M599 | Type1 | PND group vs. control group | Plasma | Human | Up |
| Study M683 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M683 | Type2 | CUMS + high dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M683 | Type2 | CUMS + low dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M683 | Type2 | CUMS + middle dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M691 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M691 | Type2 | CUMS + low dose of Chaihu-Baishao group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M691 | Type2 | CUMS + low dose of Chaihu group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M691 | Type2 | CUMS + low dose of Baishao group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M704 | Type3 | high dose of sertraline group vs. control group | Testis | Sprague-Dawley rat | Down |
| Study M704 | Type3 | high dose of sertraline group vs. control group | Adrenal gland | Sprague-Dawley rat | Down |
| Study M704 | Type3 | middle dose of sertraline group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M704 | Type3 | low dose of sertraline group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M704 | Type3 | middle dose of sertraline group vs. control group | Testis | Sprague-Dawley rat | Down |
| Study M704 | Type3 | low dose of sertraline group vs. control group | Testis | Sprague-Dawley rat | Down |
| Study M704 | Type3 | high dose of sertraline group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M704 | Type3 | low dose of sertraline group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M704 | Type3 | high dose of sertraline group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M704 | Type3 | middle dose of sertraline group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M705 | Type1 | maternal separation group vs. control group | Plasma | C57BL/6 mouse | Down |
| Study M802 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M802 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M945 | Type1 | MDD group vs. control group | Serum | Human | Down |